Welcome to our new Executives-in-Residence!
We are very excited about our six new CTV Executives-in-Residence (XIRs), who are available to any Columbia researcher, student, or staff for advice on how to best commercialize their technologies. This class of XIRs has expertise spanning a range of fields including software, life sciences, drug discovery, engineering, angel investing, intellectual property licensing and more, with experience at various startups as well as Kleiner Perkins, Bell Labs, Intel, Roche, HP, Genentech, and other publicly traded companies. You can also see their full bios here, but in brief:
- David Murphy, CTV’s “Founding XIR,” returns to Columbia! David has held senior executive roles at HP, Mercury Interactive, Asera Systems, Tivoli/IBM and McKinsey over a 30 year+ technology industry career; has been an EIR at Garnett-Helfrich and a member of numerous start-up Boards; most recently was President/COO of cybersecurity company Blue Coat Systems which was sold to Bain Capital earlier this year;
- Gordon Stewart, most recently Director of Global IP Strategy and Portfolio Management at Bell-Labs / Alcatel Lucent, brings 20 years of experience in IP licensing, business development, and patent portfolio management, in both corporate and university settings and in both the physical and life sciences;
- Nicholas Wood, one of Intel’s early employees, has been a founder and advisor to many high-tech startups and is currently investing in clean energy, water, instrumentation and medical device markets;
- Diego Carranza, a healthcare executive from Roche/Genentech and Forest Laboratories, brings diverse U.S. and international expertise in both pharmaceutical and consumer health businesses across disease areas and markets;
- Barry Kappel was most recently part of the senior team at biotech startup ContraFect, focused on therapeutic protein and antibody products for infectious diseases, which went public on the NASDAQ;
- Natalie Tucker is Director of Clinical and Medical Strategies at MELA Sciences, Inc., a medical device company focused on providing diagnostic aids for the early detection of melanoma.
Our XIRs offer an invaluable resource to the Columbia community by helping to accelerate the path of many promising technologies toward market success. For those in the Columbia community, speak with your CTV licensing officer or email email@example.com to arrange a meeting with any of our XIRs.
Executive Director, CTV
VP for Intellectual Property & Technology Transfer